OncoMatch/Clinical Trials/NCT06811844
Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC
Is NCT06811844 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies multiple treatments including Two-cycle induction chemotherapy + immunotherapy and Three-cycle induction chemotherapy + immunotherapy for nasopharyngeal neoplasms.
Treatment: Two-cycle induction chemotherapy + immunotherapy · Three-cycle induction chemotherapy + immunotherapy — This prospective, phase II, multicenter, randomized controlled study aims to compare the complete response rate and long-term survival outcomes of two-cycle and three-cycle induction therapy with modified TPF regimens combined with camrelizumab in patients with locally advanced nasopharyngeal carcinoma.
Check if I qualifyExtracted eligibility criteria
Cancer type
Head and Neck Squamous Cell Carcinoma
Disease stage
Required: Stage T1-4N2-3M0 (UICC/AJCC TNM staging system, 8th edition)
clinical staging T1-4N2-3M0 (according to the UICC/AJCC TNM staging system, 8th edition)
Performance status
ECOG 0–1(Restricted strenuous activity)
Prior therapy
Lab requirements
Blood counts
Normal major organ function, with basic normal results in hematology, biochemistry, and coagulation tests
Kidney function
Normal major organ function, with basic normal results in hematology, biochemistry, and coagulation tests
Liver function
Normal major organ function, with basic normal results in hematology, biochemistry, and coagulation tests
Cardiac function
Unwell-controlled cardiac clinical symptoms or diseases [excluded]
Normal major organ function, with basic normal results in hematology, biochemistry, and coagulation tests; Unwell-controlled cardiac clinical symptoms or diseases [excluded]
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify